Good news for Gautam Adani, THIS stock likely to jump by 32 percent, brokerage issues big statement for investors, says buy it for…

The stock's 52-week low is Rs 993.85. As per Nuvama's report, the company's strong cash flow and robust balance sheet provide ...

Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer

Revised transaction values Metsera at up to $86.25 per share -- Metsera's Board of Directors unanimously recommends that Metsera stockholders approve the adoption of the amended Pfizer merger ...

Metsera, Inc.: Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer

Revised transaction values Metsera at up to $86.25 per share Metsera's Board of Directors unanimously recommends that Metsera stockholders approve the adoption ...